Stay updated with breaking news from Gregorym Marcus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not reduce recurrent stroke vs aspirin in the ARCADIA trial.
Researchers at UCSF have discovered an unexpectedly high rate of COVID rebound following treatment with Paxlovid. A group of scientists from the University of California, San Francisco, discovered that Paxlovid (Nirmatrelvir-ritonavir) was ineffective in lowering the chances of vaccinated, non-hosp
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, no
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, no
A study has found another reason to catch more Z’s: Poor sleep is tied to significantly higher odds of experiencing atrial fibrillation.